Xencor Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Hi, everyone. It's Andy Singer. Welcome to day 2 of the Credit Suisse Annual Healthcare Conference, virtual, of course, this year. Delighted to be joined by Bassil Dahiyat who is the, as you know, Founder and Chief Executive of Xencor. It's a company that I've known for a long, long time. They've had tremendous success in getting products to patients, pushing the science and really building out the platform into a lot of new and exciting areas beyond the early days in Fc engineering and to bispecifics, engineered cytokines and a lot of other really exciting areas.
So Bassil will take you through the presentation for about 20, 25 minutes, and then we'll have some Q&A. So Bassil, over to you.
Thanks very much, Andy. It's great to be here at CS and to see you virtually today. I'm going to share my screen now. Hopefully, that works. You're seeing slides. Is that correct?
Great. So
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |